4.2% in patients with AKI and 3.6% in those without AKI (P = 1.000). Conclusion The incidence of AKI after pediatric liver transplantation was 46.2%. Increased preoperative total bilirubin level and increased intraoperative blood loss were independently associated with the development of AKI. AKI was associated with prolonged hospitalization.
Introduction
Previous studies involving adults have shown that acute kidney injury (AKI) is common after liver transplantation, and it may lead to serious complications including the development of chronic kidney disease and increased mortality [1] [2] [3] . A single-center study involving 424 adult liver transplant recipients [3] that used the Kidney Disease: Improving Global Outcomes criteria to define postoperative AKI reported that AKI occurred in 52% of patients and that the development of AKI negatively impacted short-term and long-term graft survival. Many patient-and procedurerelated risk factors for AKI after adult liver transplantation have been identified, including female gender [3] , obesity [3, 4] , preoperative chronic kidney disease [5, 6] , diabetes mellitus [1, 7, 8] , high model for end-stage liver disease score [4, [8] [9] [10] [11] [12] , high Child-Pugh score [3] , and large amount of blood loss [6, 9, 13] . These findings may help identify patients at a high risk for AKI and improve perioperative management to prevent or ameliorate AKI.
However, in contrast to adult liver transplantation, data on the incidence of, risk factors for, and association with outcomes of AKI in pediatric liver transplant recipients are 1 3 scarce. Because adults and children differ in terms of the etiology of liver disease, coexisting conditions, and reserve capacity of the kidney, the epidemiological features of AKI after pediatric liver transplantation may differ from those after adult liver transplantation.
Therefore, we conducted a retrospective cohort study to determine the incidence of AKI after pediatric liver transplantation. We hypothesized that AKI would be common among pediatric liver transplant recipients. In addition, we investigated the risk factors for AKI and association of AKI with outcomes.
Methods
The ethics committee of Kyoto University Hospital approved this single-center retrospective study (approval number: R0060; April 14, 2016) and waived the requirement for informed consent. We included patients aged between 3 months and 18 years who underwent liver transplantation at Kyoto University Hospital from January 2006 to March 2015. Patients who had end-stage renal disease preoperatively (patients having an estimated glomerular filtration rate <35 ml/min/1.73 m 2 , as determined using the modified Schwartz equation [14] , or those undergoing hemodialysis within 2 weeks before the surgery) were excluded because AKI assessment was no longer relevant.
Perioperative management
At our institution, anesthetic drugs used for liver transplantation are standardized: anesthesia was induced using propofol (1-1.5 mg/kg) and remifentanil (0.1 µg/kg/min), and maintained using sevoflurane (1-1.5%) and remifentanil (0.1-0.3 µg/kg/min). During the surgery, red blood cell concentrate was administered to maintain a hematocrit of 25-30%. Although use of vasopressors was decided by the attending anesthesiologist, the first-line vasopressor used during the surgery was phenylephrine. If phenylephrine was ineffective, dopamine, norepinephrine, vasopressin, or epinephrine was considered.
Immunosuppression was provided according to the institutional protocol, as previously described [15] . The basic immunosuppressive regimen comprised a calcineurin inhibitor (tacrolimus or cyclosporine) and low-dose corticosteroid. Additionally, recipients of blood-type-incompatible liver grafts received preoperative anti-CD20 antibody (rituximab, 375 mg/m 2 ) with preoperative plasma exchange, postoperative hepatic artery infusion of prostaglandin E1 (0.01 µg/ kg/min) and methylprednisolone (125 mg/day), and postoperative cyclophosphamide (2 mg/kg/day), followed by mycophenolate mofetil (starting dose, 500 mg/day; maintenance dose, 1000 mg/day).
Data collection
The following patient and perioperative variables were obtained from patient medical records: patient characteristics (age, gender, height, weight, etiology of liver disease, preoperative laboratory test results, and Child-Pugh classification), operative variables (re-transplantation, intraoperative blood loss, graft-to-recipient weight ratio, blood-type compatibility, and cold and warm ischemia times), and postoperative course [urine output, laboratory test results, postoperative hemodialysis, duration of postoperative intensive care unit (ICU) and hospital stays, and in-hospital mortality].
Outcomes
The primary outcome was AKI, defined as any stage of AKI according to the Kidney Disease: Improving Global Outcomes guidelines [16] . The AKI stages were based on the serum creatinine (SCr) concentration measured daily for 7 days after surgery and urine output measured every 2 h during the postoperative ICU stay (for 7 days after surgery if the postoperative ICU stay continues longer than 7 days). The most recent SCr level measured before the surgery was used as the baseline value.
Statistical analyses
Continuous variables were presented as medians (interquartile range) and compared using the Mann-Whitney U test; categorical variables were presented as numbers (percentage) and compared using the Pearson chi-square test or Fisher exact test, as appropriate. We applied multivariable logistic regression analysis to determine the independent predictors of postoperative AKI. On the basis of clinical relevance and a literature search for factors shown to be associated with AKI after adult liver transplantation, 12 variables [age, gender, preoperative laboratory test results (estimated glomerular filtration rate, serum albumin, prothrombin activity, and total bilirubin), hepatic encephalopathy, ascites, re-transplantation, intraoperative blood loss, graft-to-recipient weight ratio, and warm ischemia time] were considered for entry into the model [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . Multicollinearity among variables was assessed by the variance inflation factor with a reference value of 10. A stepwise method combined with a bootstrap procedure [17] was used for variable selection. After considering all variables, a stepwise (forward and backward) variable selection minimizing Akaike information criteria was repeated for each of the 1000 bootstrap resamplings, and variables selected in 50% or more of the bootstrap models were retained in the final model. The discrimination and the calibration of the model were assessed using the c-statistic and the Hosmer-Lemeshow goodness-of-fit test, respectively. The primary multivariable analysis was based on data from patients for whom complete information on all variables was available. Sensitivity analyses were performed with the use of multiple imputation by chained equations. Missing values were imputed conditional on the nonmissing values of the other variables including age, gender, estimated glomerular filtration rate, serum albumin, prothrombin activity, total bilirubin, hepatic encephalopathy, ascites, re-transplantation, intraoperative blood loss, graft-torecipient weight ratio, warm ischemia time, and the presence or absence of AKI. For each outcome, multiple imputation results were obtained from 100 imputed datasets.
Time-to-event analyses were used to compare the length of ICU and hospital stays. Patient data were censored at the time of death. Medians and interquartile ranges were obtained using Kaplan-Meier analyses, and the log-rank test was used to assess differences between groups.
The sample size was determined by including all cases during the study period to maximize the power. Previous studies suggested that at least 8 to 10 events per variable were required for reliable multivariable logistic regression analysis [18, 19] . We assumed 20 eligible surgeries per year and predicted the prevalence of AKI to be 33% to 78% on the basis of published reports concerning adult liver transplantation. Thus, we estimated that we could conduct multivariable logistic regression with 6 to 14 variables using our dataset.
All statistical tests were two tailed, and a P value <0.05 was considered to be statistically significant. All statistical analyses were performed using the statistical program R (http://cran.r-project.org).
Results
A total of 165 pediatric patients underwent liver transplantation during the study period. Of these, 156 subjects were analyzed, after excluding 8 patients who had preoperative end-stage renal disease and 1 patient whose data on postoperative urine output were missing and, therefore, for whom the presence or absence of AKI could not be judged. Only one case of cadaveric liver transplantation was included; all others were living donor liver transplantations. The median age of the study participants was 2 years (interquartile range, 0-6); 90 patients (57.7%) were female. AKI occurred in 72 patients (46.2%); 34 (21.8%) had stage 1, 32 (20.5%) had stage 2, and 6 (3.8%) had stage 3 AKI. AKI defined according to the SCr level alone developed in 53 patients (34.0%), and AKI defined according to urine output alone developed in 35 patients (22.4%). In 19 of the 35 patients (54.3%) who met the urine output criterion for AKI, the diagnosis of AKI would have been missed if only the SCr criterion had been used (Fig. 1) .
Univariable associations between perioperative characteristics and postoperative AKI are presented in Table 1 . Variables significantly associated at the 5% level were preoperative prothrombin activity, preoperative total bilirubin, and intraoperative blood loss.
One hundred forty-three patients were included in the multivariable logistic regression analysis after excluding 13 patients (8.3%) with missing variables. After stepwise variable selection with bootstrap resampling, preoperative total bilirubin and intraoperative blood loss were chosen in more than 50% of resamples (preoperative total bilirubin, 72.6%; intraoperative blood loss, 57.0%) and included in the final model. In the final multivariable model, increased preoperative total bilirubin level and increased intraoperative blood loss were independently associated with the development of AKI (Table 2) . None of the variance inflation factor values was greater than 10, indicating that there was no multicollinearity. The final model had acceptable discrimination [c-statistic, 0.651; 95% confidence interval (CI), 0.559-0.742] and calibration (Hosmer-Lemeshow statistic P value, 0.472). When using multiple imputation to account for missing values, the point estimates for the associations were not substantially affected; the adjusted odds ratio for total bilirubin was 1.04 (95% CI, 1.01-1.08; P = 0.024) and that for intraoperative blood loss was 1.02 (95% CI, 0.99-1.06; P = 0.108).
We assessed the association of AKI with the lengths of ICU and hospital stays and in-hospital mortality. There was no significant difference in ICU stay between patients with and without AKI [median (interquartile range, IQR), 4 (4-5) vs. 4 (4-5) days; P = 0.094; Fig. 2a] , whereas AKI was significantly associated with prolonged hospitalization [median (IQR), 61 (44-100) vs. 46 (35-78) days; P = 0.028; Fig. 2b ]. We could not find a significant association between AKI and in-hospital mortality (4.2% in patients with AKI and 3.6% in those without; P = 1.000). Clinical outcomes stratified by AKI stages or AKI definitions are presented in Supplemental Data 1. 
Discussion
In this retrospective study of 156 children aged between 3 months and 18 years who underwent liver transplantation, we found that the incidence of postoperative AKI according to recent guidelines was 46.2%. In addition, increased preoperative total bilirubin concentration and increased intraoperative blood loss were independently associated with the development of AKI. AKI was significantly associated with a prolonged hospital stay.
To the best of our knowledge, this is the first study to investigate the incidence of postoperative AKI after pediatric liver transplantation. Children are assumed to have a low prevalence of chronic diseases such as diabetes mellitus and chronic kidney disease, both of which have been shown to be risk factors for AKI after liver transplantation [1, [5] [6] [7] [8] . In our study, only one patient had diabetes mellitus and no patient had preoperative renal insufficiency with an estimated glomerular filtration rate of <60 ml/min/1.73 m 2 . Despite these low prevalences of risk factors, the incidence of AKI in the current study (46.2%) was similar to that reported in adult liver transplantation (39.4-56.6%) [3, 20, Height data were missing in 1 patient with acute kidney injury (AKI) and 3 without AKI, and estimated glomerular filtration rate could not be calculated in these patients; blood loss data were missing in 5 patients with AKI and 3 without AKI; graft-to-recipient weight ratio data were missing in 4 patients with AKI and 3 without AKI; cold ischemia time data were missing in 6 patients with AKI and 4 without AKI; warm ischemia time data were missing in 6 patients with AKI and 3 without AKI AKI acute kidney injury
Variables
All patients (n = 156) Acute kidney injury P value Absent (n = 84) Present (n = 72) Compared with applying the SCr criterion alone, incorporating oliguria into the diagnostic criteria increased the measured incidence of AKI from 34.0% to 46.2%. Assessment of AKI according to the SCr level alone failed to identify AKI in 54.3% of the patients with low urine output. These findings are similar to our previous study in adult liver transplantation patients wherein we demonstrated that 44.7% of patients with oliguria were missed when we diagnosed AKI using the SCr level alone [15] . Epidemiological study of AKI in critically ill children and young adults showed that low urine output without increased SCr conferred an increased risk for mortality [22] . Our findings reveal the importance of monitoring both the SCr level and the urine output.
One of the risk factors for AKI identified in our study was increased preoperative total bilirubin level. This finding is in line with previous studies of AKI in adult liver transplant recipients, reporting that a high model for end-stage liver disease score or Child-Pugh score (both are calculated using the total bilirubin level) were independent risk factors for AKI [3, 4, [8] [9] [10] [11] [12] . Increased preoperative total bilirubin might reflect the severity of the underlying liver disease. Intraoperative blood loss was also found to be an independent risk factor for postoperative AKI in our study, as was shown in previous studies in adult liver transplant recipients [6, 9, 13] . Blood loss appears to be a surrogate marker for surgical complexity or intraoperative adverse events, and hemodynamic instability or anemia resulting from massive bleeding might reduce oxygen delivery to the kidneys and cause kidney injury.
Prolonged hospitalization of patients with AKI might suggest that the postoperative course of these patients is complicated, although this finding is merely an association and cannot imply a causal relationship. Because inhospital mortality in the study participants was very low (3.8%), this study is underpowered to assess differences in mortality by AKI status. However, AKI was shown to be associated with poor outcomes including increased mortality in critically ill children [22] and children undergoing cardiac surgery [23] [24] [25] [26] .
Limitations of our study are as follows. This was a single-center study, which may reduce the generalizability of our results. Most patients in this study underwent living donor liver transplantation; we cannot confirm whether our findings can be extrapolated to pediatric patients undergoing cadaveric liver transplantation. We used urine output measured every 2 h instead of every hour to define AKI, because urine output measurement is performed every 2 h at our ICU; this modification of the definition of AKI might have affected the incidence of AKI.
In conclusion, the incidence of postoperative AKI after pediatric liver transplantation was 46.2%. Increased preoperative total bilirubin level and increased intraoperative blood loss were independently associated with the development of AKI. AKI was significantly associated with a prolonged hospital stay.
